By Jonathan Gould
FRANKFURT, Dec 13 (Reuters) - Fresenius Medical Care, the
world's largest dialysis group, said a group of plaintiffs in
the United States had moved to consolidate wrongful death
lawsuits against the company over its NaturaLyte and GranuFlo
The suits generally allege that the two products carried
inadequate labeling and warnings, causing harm to patients, FMC
said, adding that it considered the suits to be without merit
and was vigorously defending against them.
The company's chief executive Ben Lipps said in a statement
that FMC's actions related to the products were appropriate and
"Both products are safe and effective and were reviewed and
cleared by the Food and Drug Administration several years ago,"
"I am confident of our position on this medical issue," he
FMC's North American subsidiary received a subpoena from the
Massachusetts district attorney on Dec. 7 requesting documents
in the case and was cooperating fully, the company said.
Follow us on Twitter @ReutersLegal | Like us on Facebook